Deutsche Bank
GILD icon

Deutsche Bank’s Gilead Sciences GILD Stock Holding History

Deutsche Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-620
Closed -$46K – 4310
2020
Q1 		$46K Sell
620
-286
-32% -$19.8K ﹤0.01% 3583
2019
Q4 		$58K Hold
906
– – ﹤0.01% 3897
2019
Q3 		$57K Hold
906
– – ﹤0.01% 3862
2019
Q2 		$61K Buy
906
+670
+284% +$44.1K ﹤0.01% 4431
2019
Q1 		$15K Sell
236
-104
-31% -$6.91K ﹤0.01% 4843
2018
Q4 		$21K Sell
340
-2,278
-87% -$159K ﹤0.01% 4724
2018
Q3 		$202K Sell
2,618
-2,597
-50% -$196K ﹤0.01% 4237
2018
Q2 		$369K Buy
5,215
+3,250
+165% +$230K ﹤0.01% 3998
2018
Q1 		$147K Sell
1,965
-1,380
-41% -$110K ﹤0.01% 4336
2017
Q4 		$239K Buy
3,345
+37
+1% +$2.81K ﹤0.01% 3951
2017
Q3 		$267K Sell
3,308
-3,520
-52% -$269K ﹤0.01% 3731
2017
Q2 		$482K Buy
6,828
+3,795
+125% +$253K ﹤0.01% 3472
2017
Q1 		$205K Buy
3,033
+2,031
+203% +$143K ﹤0.01% 3580
2016
Q4 		$70K Sell
1,002
-3,453
-78% -$257K ﹤0.01% 4234
2016
Q3 		$352K Buy
4,455
+4,081
+1,091% +$332K ﹤0.01% 3364
2016
Q2 		$31K Sell
374
-677
-64% -$60.1K ﹤0.01% 4606
2016
Q1 		$96K Sell
1,051
-3,848
-79% -$347K ﹤0.01% 4040
2015
Q4 		$495K Buy
4,899
+1,126
+30% +$117K ﹤0.01% 3277
2015
Q3 		$370K Buy
3,773
+2,713
+256% +$301K ﹤0.01% 3524
2015
Q2 		$124K Sell
1,060
-700
-40% -$76.5K ﹤0.01% 4124
2015
Q1 		$172K Sell
1,760
-3,890
-69% -$395K ﹤0.01% 3858
2014
Q4 		$532K Buy
5,650
+4,000
+242% +$414K ﹤0.01% 3630
2014
Q3 		$175K Sell
1,650
-450
-21% -$44.1K ﹤0.01% 4156
2014
Q2 		$174K Buy
2,100
+600
+40% +$46.7K ﹤0.01% 4222
2014
Q1 		$2K Sell
1,500
-6,109
-80% -$479K ﹤0.01% 5347
2013
Q4 		$226K Sell
7,609
-227
-3% -$15.8K ﹤0.01% 3631
2013
Q3 		$151K Buy
7,836
+896
+13% +$53.5K ﹤0.01% 4256
2013
Q2 		$93K Buy
+6,940
New +$362K ﹤0.01% 4262

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank's GILD Position: Q2 2026 in Review

Deutsche Bank increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $138M and bringing the position to 7,269,170 shares worth $918M. The position accounts for 0.27% of the portfolio, ranked #77.

Deutsche Bank first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.16B in Q4 2015. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Deutsche Bank held 7,269,170 shares of Gilead Sciences worth $918M as of Q2 2026.
  • Deutsche Bank bought 1,046,842 Gilead Sciences shares in Q2 2026, an estimated $138M.
  • Gilead Sciences made up 0.27% of Deutsche Bank's portfolio in Q2 2026, its #77 holding.
  • Deutsche Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Gilead Sciences position peaked at $1.16B in Q4 2015.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.